Matthew represents investors, policyholders, beneficiaries, and families who have suffered financial loss. His practice focuses on investment losses, professional negligence, securities litigation, and financial misconduct.

Before becoming a lawyer, Matthew worked as a protein biochemist conducting HIV and cancer research. His scientific background gives him a unique ability to analyze complex evidence and understand sophisticated financial and technical issues. He is particularly skilled at helping clients understand situations that are often difficult to navigate.

Matthew has extensive experience representing plaintiffs in complex litigation, including investment and securities matters, professional liability claims, product liability actions, and institutional abuse cases. He has appeared before the Ontario Superior Court of Justice, the Commercial List, and the Court of Appeal for Ontario, and has been involved in numerous trials, certification motions, summary judgment motions, and other significant proceedings.

Matthew is a frequent writer, speaker, and lecturer on securities litigation. He writes a securities law column for Investment Executive and regularly presents on issues affecting investors and developments in securities law and investor protection.

‍